BNB PLUS CORP. (BNBX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jul 10Jul 15Jul 20Jul 23Jul 28Jul 31Aug 5Aug 10

Key dataAug 10, 2026

Open$0.13

From 52W high−97.10%

Volume35400.00

Market cap$923797.45

P/E (TTM)—

P/S (TTM)0.4x

Div yield—

Key dataAug 10, 2026

Open

$0.13

From 52W high

−97.10%

Volume

35400.00

Market cap

$923797.45

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.0x

P/E (TTM)

—

RSI (14)

41.7

MomentumView details →

1D Return

+0.00%

YTD Return

−88.62%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

0.0x

EV/Sales

−0.2x

P/S (TTM)

0.4x

P/B (TTM)

0.1x

ProfitabilityView details →

Gross Margin

43.49%

Net Margin

−1646.94%

EBITDA Margin

−1657.56%

ROE (TTM)

−275.69%

ROA (TTM)

−252.85%

Asset Turnover

0.12x

GrowthView details →

Revenue YoY

−39.60%

EPS YoY

—

FCF YoY

+1.08%

Revenue CAGR 3Y

−51.00%

EPS CAGR 3Y

−96.67%

EBITDA YoY

—

MomentumView details →

1D Return

+0.00%

YTD Return

−88.62%

1Y Return

—

RSI (14)

41.7

vs 50D SMA

−53.41%

vs 200D SMA

−87.88%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

1.82x

Quick Ratio

1.74x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.68

EPS Surprise

—

Beats (12Q)

7/12

Next Q EPS Est

—

Avg Surprise (4Q)

104.17%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

2.09M

Net Income (TTM)

−34.48M

Op. CF (TTM)

−13.79M

Latest newsMore news →

Robert B. Catell, Joseph D. Ceccoli and Dr. Yacov Shamash resigned as directors of BNB Plus Corp., effective September 3, 2026, and were succeeded by Richard Shorten, Todd Larsen and Lok Lee respectively.17d ago

BNB Plus agreed to pay $1 million in cash and issue 200,000 preferred shares to Cypress LLC and Cypress Management LLC to settle and terminate their digital-asset management and strategic-adviser agreements, following Nasdaq's suspension of BNBX stock.52d ago

Similar companies

Jaguar Health, Inc.JAGX Nexera Technologies LtdNEXR Hepion Pharmaceuticals, Inc.HEPA NKGen Biotech, Inc. WarrantsNKGNW IO Biotech, Inc.IOBT Scinai Immunotherapeutics Ltd.SCNI Find similar companies →

Latest newsMore news →

Robert B. Catell, Joseph D. Ceccoli and Dr. Yacov Shamash resigned as directors of BNB Plus Corp., effective September 3, 2026, and were succeeded by Richard Shorten, Todd Larsen and Lok Lee respectively.17d ago BNB Plus agreed to pay $1 million in cash and issue 200,000 preferred shares to Cypress LLC and Cypress Management LLC to settle and terminate their digital-asset management and strategic-adviser agreements, following Nasdaq's suspension of BNBX stock.52d ago